NDRA Stock Analysis: Buy, Sell, or Hold?
NDRA - ENDRA Life Sciences Inc. Common Stock
$4.73
0.17 (3.70%)
▲
5d:
+10.74%
30d:
-17.62%
90d:
+43.3%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When NDRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: NDRA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: NDRA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: NDRA is currently trading at $4.73, which is considered slightly low relative to its 30-day fair value range of $4.59 to $5.57.
Technical Outlook: Technically, NDRA is in a uptrend. Immediate support is located at $4.21, while resistance sits at $5.98. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: NDRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+448.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NDRA is in a uptrend. Immediate support is located at $4.21, while resistance sits at $5.98. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: NDRA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $25.00 (+448.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$4.59 -
$5.57
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 448.2% below Wall St target ($25.00)
Trading Range Analysis
30-Day Trading Range
$4.59 -
$5.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$4.21
Resistance Level
$5.98
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.50
Wall Street Target
$25.00
(+448.2%)
Share & Embed Analysis
Last updated: June 15, 2026 1:58 PM ET
Data refreshes hourly during market hours. Next update: 2:58 PM
Data refreshes hourly during market hours. Next update: 2:58 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NDRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$599 | 60 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$242 | 63 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$141 | 59 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$260 | 54 HOLD |
